Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Total Current Liabilities: 2023-2024

Historic Total Current Liabilities for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $8.9 million.

  • Compass Therapeutics' Total Current Liabilities rose 179.99% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 179.99%. This contributed to the annual value of $8.9 million for FY2024, which is 13.75% up from last year.
  • As of FY2024, Compass Therapeutics' Total Current Liabilities stood at $8.9 million, which was up 13.75% from $7.8 million recorded in FY2023.
  • Compass Therapeutics' Total Current Liabilities' 5-year high stood at $8.9 million during FY2024, with a 5-year trough of $7.8 million in FY2023.
  • In the last 2 years, Compass Therapeutics' Total Current Liabilities had a median value of $8.3 million in 2023 and averaged $8.3 million.
  • Data for Compass Therapeutics' Total Current Liabilities shows a peak YoY climbed of 13.75% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Compass Therapeutics' Total Current Liabilities stood at $7.8 million in 2023, then grew by 13.75% to $8.9 million in 2024.